Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials. - Wikidata - wikimedia - TriplyDB

Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials.

Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials.

http://www.wikidata.org/entity/Q46522445

about

Randomized Trial of a Web-Based Intervention to Address Barriers to Clinical Trials ResearchMatch: a national registry to recruit volunteers for clinical research.Sample size determination for fold-increase endpoints defined by paired interval-censored data.Participation of older newly-diagnosed cancer patients in an observational prospective pilot study: an example of recruitment and retention State-of-the-science of patient navigation as a strategy for enhancing minority clinical trial accrual.Racial differences in parents' distrust of medicine and research.Statewide cancer clinical trial navigation service.Promoting Factors and Barriers to Participation in Early Phase Clinical Trials: Patients Perspectives.Barriers to participation in cancer prevention clinical trials.Technical desiderata for the integration of genomic data into Electronic Health Records.Breast cancer survivors willingness to participate in an acupuncture clinical trial: a qualitative study Unique perception of clinical trials by Korean cancer patients Psychosocial barriers and facilitators to clinical trial enrollment and adherence for adolescents with cancer Barriers to recruitment of rural patients in cancer clinical trials.Rural-urban differences in discussions of cancer treatment clinical trials.Culturally and linguistically diverse patient participation in glioma research.Attitudinal barriers to participation in oncology clinical trials: factor analysis and correlates of barriers Cancer Research Participation Beliefs and Behaviors of a Southern Black Population: A Quantitative Analysis of the Role of Structural Factors in Cancer Research Participation.The bottleneck effect in lung cancer clinical trials.Retention of clinical trial participants in a study of nongonococcal urethritis (NGU), a sexually transmitted infection in men.A pilot study of a culturally targeted video intervention to increase participation of African American patients in cancer clinical trials.Socioeconomic and clinical factors are key to uncovering disparity in accrual onto therapeutic trials for breast cancer.Hematopoietic cell transplantation for autoimmune disease: updates from Europe and the United States.Clinical trial awareness: Changes over time and sociodemographic disparities.Removing barriers to participation in clinical trials, a conceptual framework and retrospective chart review study.Discussions of cancer clinical trials with the National Cancer Institute's Cancer Information Service Patient income level and cancer clinical trial participation.Pilot intervention outcomes of an educational program for biospecimen research participation.Recruiting underserved populations to dermatologic research: a systematic review Cancer patients' awareness of clinical trials, perceptions on the benefit and willingness to participate: Korean perspectives.The impact of insurance on access to cancer clinical trials at a comprehensive cancer center Nonsurgical management of cervical cancer: locally advanced, recurrent, and metastatic disease, survivorship, and beyond.A Patient Focused Solution for Enrolling Clinical Trials in Rare and Selective Cancer Indications: A Landscape of Haystacks and Needles.Factors associated with enrollment of African Americans into a clinical trial: results from the African American study of kidney disease and hypertension.African American men's and women's perceptions of clinical trials research: focusing on prostate cancer among a high-risk population in the South.Physician-related factors involved in patient decisions to enroll onto cancer clinical trials.Attitudes and barriers towards participation in an acupuncture trial among breast cancer patients: a survey study.Recommendations for enhancing clinical trials education: a review of the literature.Obstacles to participation in randomised cancer clinical trials: a systematic review of the literature.Applying a Conceptual Framework to Maximize the Participation of Diverse Populations in Cancer Clinical Trials

P2860

Q27313405-DD62E8EC-4DBC-40E1-8DDB-1FD91D0A39D2 Q30485212-0BEA950C-1389-45C3-87AA-366E25EC7951 Q31052614-868EAAF6-C96C-4B5D-8C05-F280CCC55A6C Q33491875-763ECEC4-D09A-4696-AB41-578AE0A2DD57 Q33689536-99466743-5A19-416A-A8D1-E166341E05FC Q33743697-D121286F-E246-48B3-A21B-4265ECF4FC36 Q33846172-819856B8-959F-488C-AC17-01620F1BAFA9 Q33956979-7655A384-5741-4EB4-9AA2-FD906047AE09 Q33981798-FD544BF6-85A3-45A0-A1B2-3244D504F380 Q34120006-D6387791-4085-461B-A9EF-0D076D258952 Q34172706-D0DD0BD4-1F05-4684-A8DC-6E932F10DD46 Q34509527-BF36E8BF-BBD2-4D71-8B0A-D69B16187BF6 Q34649686-07011AE1-D2ED-4338-A659-BD16E812C3A7 Q34974911-A8000AA7-23B5-4F62-AECC-566A3D3380CC Q35182004-F7A39FF3-EBD5-45A0-B054-9AD20C620579 Q35206198-48782ADF-6DA4-4E9A-9049-45EA2F010C44 Q35563968-9DB68523-0FDB-446B-9CED-36A6A16D4577 Q35598300-6C12B70B-0E7F-4D9D-8B9E-634170551BBE Q35850218-C43D1A38-FDF3-4BE1-B513-FC889459F63E Q35942053-E2BA340A-93EC-43EA-B81D-593BDAF2FA2B Q35989988-C09CAA15-B5DE-41D2-ABDF-CFC9611114A0 Q36148915-BF8406A0-DFF2-46FC-81CD-921207AFBB32 Q36252940-CD4743FF-96AF-4A4B-8243-AB13F2EC89C3 Q36341764-D28BC2E1-8468-4B4F-B599-0A53AA295B36 Q36552760-C72C75B0-DFE8-4126-B54B-5B60A4CB42B5 Q36580597-74C47DC6-2847-43B7-AB80-2B4B1437A369 Q36589626-24DDADED-B201-4E12-B39A-C74EAC5DFAFD Q36685002-0D89E8E5-1856-42F8-A0ED-B3D66803CBDB Q36819871-D7885578-2E6E-4F89-8DB1-367C8C9103DA Q36977562-E457E23F-88B5-435B-9226-3B96E10EBD77 Q37023806-75834C10-6908-4C2A-A4EB-B24BB2C48C5B Q37036792-0A048D64-F909-4AE2-B584-71D8F3431389 Q37124478-24B28FBB-0009-4E94-89A2-475D7275430C Q37156595-13294AAA-3032-4776-A335-96800C52593A Q37281689-8EEBE066-B1EA-460F-B944-BC022B8BB718 Q37466394-076F4104-9F81-46A2-8C14-DEAF715BB748 Q37485874-AD0833AA-12C9-428E-BE37-3B4FB58E7E82 Q37791483-CF6FFB38-25EC-4850-915F-FF5DD85F4013 Q37984632-7266BE76-50FE-45D0-AD6E-30A8AAAA42F1 Q38374455-EAB247AA-589D-4BD2-99C3-5E7404BED9EF

P2860

Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials.

http://www.wikidata.org/entity/Q46522445

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Evaluation of factors affectin ...... ate in cancer clinical trials.

@en

Evaluation of factors affectin ...... ate in cancer clinical trials.

@nl

type

label

Evaluation of factors affectin ...... ate in cancer clinical trials.

@en

Evaluation of factors affectin ...... ate in cancer clinical trials.

@nl

prefLabel

Evaluation of factors affectin ...... ate in cancer clinical trials.

@en

Evaluation of factors affectin ...... ate in cancer clinical trials.

@nl

P1433

Q46522445-9CFE8ABC-F4A2-4168-B071-6680DFE8FBCD

P1476

Q46522445-0993B5CE-5453-4E80-B52C-B534FC4D5AF4

P2093

Q46522445-18232EA9-F12A-46B2-9C57-94413E132D6E

Q46522445-24D60F4D-5FDB-4D21-879C-092100D5B02A

Q46522445-2F3729E7-4078-4EB0-808A-FA6436F2C5B5

Q46522445-2FD8488A-C85A-4583-985B-57B9521F5AD6

Q46522445-35EA591F-608C-4888-AC63-64C6D3CB7B2D

Q46522445-49BC5539-95C8-4968-AB42-1AFCFB2946BC

Q46522445-7A5A3500-2016-4DC1-976D-31297AB214A1

Q46522445-7D873CF9-2197-42E7-A1D4-6676642F539D

Q46522445-AF35B7FD-29BE-47FE-B470-C07B36265A0D

Q46522445-C81692A9-A8E1-4CFE-9621-AEED4451C934

P304

Q46522445-AB35E741-C829-4F9D-8170-13CE9EAE59BB

P31

Q46522445-B0F68455-B078-4ACC-9CA5-0F1C075D1E47

P356

Q46522445-66FAC607-2498-4A0A-A021-B58E6B79650F

P407

Q46522445-9519216B-12E4-4C91-BB25-3C01B36C4B92

P433

Q46522445-DFF1D92A-9434-48D9-8E63-02055A4804F7

P478

Q46522445-DB2841F6-35BA-4896-89F5-28016633FDA9

P50

Q46522445-46AD30F5-3DFE-4D4D-947B-088B30774CE4

Q46522445-48117753-3074-4F4A-8432-ACB2394BA34D

P577

Q46522445-43AB4D6B-EEED-4840-A7D0-FFDAC27E25D0

P5875

Q46522445-8E02AB21-9CFB-4997-9753-3EB13E775FA5

P698

Q46522445-5A559551-FD4B-4DF3-86B1-F139CAD08AF8

P356

JCO.2005.02.6245

P1433

Journal of Clinical Oncology

P1476

Evaluation of factors affectin ...... ate in cancer clinical trials.

@en

P2093

Ari Umutyan

http://www.w3.org/2001/XMLSchema#string

Christine Chiechi

http://www.w3.org/2001/XMLSchema#string

Claudia Morain

http://www.w3.org/2001/XMLSchema#string

Corinne Turrell

http://www.w3.org/2001/XMLSchema#string

Cynthia L Martel

http://www.w3.org/2001/XMLSchema#string

Debora A Paterniti

http://www.w3.org/2001/XMLSchema#string

Jose Gonzalez

http://www.w3.org/2001/XMLSchema#string

Lisa Montell

http://www.w3.org/2001/XMLSchema#string

Moon S Chen

http://www.w3.org/2001/XMLSchema#string

Nora Horan

http://www.w3.org/2001/XMLSchema#string

P304

9282-9289

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2005.02.6245

http://www.w3.org/2001/XMLSchema#string

P407

P433

36

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

David R Gandara

P577

2005-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7408154

http://www.w3.org/2001/XMLSchema#string

P698

16361626

http://www.w3.org/2001/XMLSchema#string